Time-optimized NMR spectroscopy for the investigation of challenging biological systems
用于研究具有挑战性的生物系统的时间优化核磁共振波谱
基本信息
- 批准号:228568119
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:德国
- 项目类别:Independent Junior Research Groups
- 财政年份:2013
- 资助国家:德国
- 起止时间:2012-12-31 至 2019-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The main focus of the proposed group lays on the development of novel nuclear magnetic resonance (NMR) methods with an emphasis on the applicability in demanding biological systems. In this context we aim to improve the use of existing NMR resources by simultaneous detection of several experiments on different resonance frequencies. This can significantly reduce the amount of expensive NMR measurement time required to record the same amount of data (time-optimized NMR). Since a reduction of NMR measurement time is in particular crucial for the investigation of larger biological systems, NMR methods will be developed with a strong emphasis on these systems. Membrane protein folding and function was selected to offer a well suited (i.e. challenging) target for the application of the new techniques. In addition the selected targets represent very interesting areas of research on its own and the group will use this possibility to investigate e.g. how a not functional protein can insert itself into a cell-membrane to carry out its specific function. This aspect will be initially investigated using the protein Bacteriorhodopsin as our first target. A more detailed insight into this fundamental process may help to develop alternate drugs targeting membrane protein folding or may improve computer predictions of membrane protein structure and function.Furthermore we will study folding and function of our second target, the melanocortin-4 receptor (MC4R), which belongs to the pharmacologically very important class of G-Protein coupled receptors (GPCRs). Although about half of all current drugs are estimated to directly act on GPCRs, high resolution insights into these systems are very limited. We will combine the most promising conventional and non-conventional approaches to investigate structure und dynamics of the MC4R ligand system as well as ligand induced changes on the receptor side. The ligands themselves consist of several hormones (e.g adrenocorticotropic and melanocyte-stimulating hormone). The MC4R signaling pathways are involved in the control of body weight and appetite, regulation of blood pressure and the inhibition of inflammation. It is anticipated, that any high resolution insights into this system in particular in respect to receptor and ligand dynamics may on the one hand help to develop new and improved drugs targeting the MC4R signaling pathway and on the other hand may improve our understanding of GPCR function in general. The application of time-optimized NMR techniques for the investigation of the two biological targets will not only reduce the required NMR measurement time, but will also provide unique possibilities, such as the simultaneous detection of different folding states or dynamically distinct regions of the protein. Hence a strong synergy between the different aspects of the group is expected.
该小组的主要重点是开发新型核磁共振(NMR)方法,重点是在要求苛刻的生物系统中的适用性。在这方面,我们的目标是提高现有的NMR资源的使用,同时检测不同的共振频率的几个实验。这可以显著减少记录相同数量的数据所需的昂贵的NMR测量时间(时间优化的NMR)。由于减少核磁共振测量时间是特别重要的大型生物系统的调查,核磁共振方法将开发重点放在这些系统。选择膜蛋白折叠和功能为新技术的应用提供非常合适的(即具有挑战性的)靶标。此外,选定的靶点本身代表了非常有趣的研究领域,该小组将利用这种可能性来研究例如,一个没有功能的蛋白质如何将自己插入细胞膜以执行其特定功能。这方面将首先使用蛋白质细菌视紫红质作为我们的第一个目标进行研究。对这一基本过程的深入了解将有助于开发靶向膜蛋白折叠的替代药物,或改善膜蛋白结构和功能的计算机预测。此外,我们还将研究第二个靶点黑皮质素-4受体(melanocortin-4 receptor,MC 4 R)的折叠和功能,MC 4 R属于G蛋白偶联受体(G-Protein coupled receptor,GPCRs)中非常重要的一类。虽然目前所有药物中约有一半估计直接作用于GPCR,但对这些系统的高分辨率见解非常有限。我们将结合联合收割机最有前途的传统和非传统的方法来研究结构和动力学的MC 4 R配体系统,以及配体诱导的变化的受体侧。配体本身由几种激素组成(如促肾上腺皮质激素和促黑素细胞激素)。MC 4 R信号通路参与体重和食欲的控制、血压的调节和炎症的抑制。预计,对该系统的任何高分辨率见解,特别是在受体和配体动力学方面,一方面可以帮助开发新的和改进的靶向MC 4 R信号通路的药物,另一方面可以提高我们对GPCR功能的理解。应用时间优化的NMR技术研究两种生物靶标不仅可以减少所需的NMR测量时间,而且还可以提供独特的可能性,例如同时检测蛋白质的不同折叠状态或动态不同区域。因此,预计该集团的不同方面之间将产生强大的协同作用。
项目成果
期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The power, pitfalls and potential of the nanodisc system for NMR-based studies
- DOI:10.1515/hsz-2016-0224
- 发表时间:2016-12-01
- 期刊:
- 影响因子:3.7
- 作者:Viegas, Aldino;Viennet, Thibault;Etzkorn, Manuel
- 通讯作者:Etzkorn, Manuel
Reconstitution and NMR Characterization of the Ion-Channel Accessory Subunit Barttin in Detergents and Lipid-Bilayer Nanodiscs
洗涤剂和脂质双层纳米圆盘中离子通道辅助亚基 Barttin 的重构和 NMR 表征
- DOI:10.3389/fmolb.2019.00013
- 发表时间:2019
- 期刊:
- 影响因子:5
- 作者:Viennet T;Bungert-Pümke S;Elter S;Viegas A;Fahlke C;Etzkorn M
- 通讯作者:Etzkorn M
Structural and dynamic insights revealing how lipase binding domain MD1 of Pseudomonas aeruginosa foldase affects lipase activation
结构和动态见解揭示铜绿假单胞菌折叠酶的脂肪酶结合域 MD1 如何影响脂肪酶激活
- DOI:10.1038/s41598-020-60093-4
- 发表时间:2020
- 期刊:
- 影响因子:4.6
- 作者:Viegas A;Dollinger P;Verma N;Kubiak J;Viennet T;Seidel CAM;Gohlke H;Etzkorn M;Kovacic F;Jaeger KE
- 通讯作者:Jaeger KE
α-Synuclein-derived lipoparticles in the study of α-Synuclein amyloid fibril formation
- DOI:10.1016/j.chemphyslip.2019.02.009
- 发表时间:2019-05-01
- 期刊:
- 影响因子:3.4
- 作者:Falke, Marcel;Victor, Julian;Etzkorn, Manuel
- 通讯作者:Etzkorn, Manuel
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dr. Manuel Etzkorn其他文献
Dr. Manuel Etzkorn的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dr. Manuel Etzkorn', 18)}}的其他基金
Mechanistic understanding of DNA-mediated catalysis
DNA 介导的催化机制的理解
- 批准号:
401425239 - 财政年份:
- 资助金额:
-- - 项目类别:
Research Grants
Understanding the dynamic world of cell signalling and bio-catalysis through integrative native-state NMR
通过综合原生态 NMR 了解细胞信号传导和生物催化的动态世界
- 批准号:
466779182 - 财政年份:
- 资助金额:
-- - 项目类别:
Heisenberg Grants
相似国自然基金
Intelligent Patent Analysis for Optimized Technology Stack Selection:Blockchain BusinessRegistry Case Demonstration
- 批准号:
- 批准年份:2024
- 资助金额:万元
- 项目类别:外国学者研究基金项目
相似海外基金
SBIR Phase II: Thermally-optimized power amplifiers for next-generation telecommunication and radar
SBIR 第二阶段:用于下一代电信和雷达的热优化功率放大器
- 批准号:
2335504 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Cooperative Agreement
GreenTower AI: Hyper-Optimized and Self-Sustaining Cell Towers for a Net-Zero UK Telecom
GreenTower AI:英国电信零净值运营的超优化且自我维持的蜂窝塔
- 批准号:
10114180 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Collaborative R&D
STTR Phase II: Optimized manufacturing and machine learning based automation of Endothelium-on-a-chip microfluidic devices for drug screening applications.
STTR 第二阶段:用于药物筛选应用的片上内皮微流体装置的优化制造和基于机器学习的自动化。
- 批准号:
2332121 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Cooperative Agreement
Collaborative Research: Optimized frequency-domain analysis for astronomical time series
合作研究:天文时间序列的优化频域分析
- 批准号:
2307979 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Standard Grant
CRII: SHF: A Flexible, Learning-Enabled, and Multi-layer Interconnection Architecture for Optimized On-Chip Communications
CRII:SHF:一种灵活的、支持学习的多层互连架构,用于优化片上通信
- 批准号:
2245950 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Standard Grant
Development of individualized optimized neurorehabilitation to promote recovery of motor function after stroke
开发个体化优化神经康复以促进中风后运动功能的恢复
- 批准号:
23K10417 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Self-optimized graph database management system with deep learning
具有深度学习的自优化图数据库管理系统
- 批准号:
23H03406 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (B)
'Smart Ventilation' - Novel Real-Time Biosensors and Artificial Intelligence for Optimized Mechanical Ventilation in Human Lungs
“智能通气”——新型实时生物传感器和人工智能,用于优化人肺机械通气
- 批准号:
489877 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Operating Grants
Structure-based identification of optimized mutant Kir3.4 inhibitors for renoprotection (C07 (A03 + A04))
基于结构的肾脏保护优化突变型 Kir3.4 抑制剂的鉴定 (C07 (A03 A04))
- 批准号:
516847250 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Collaborative Research Centres
Understanding targeted protein degradation for design of optimized therapeutic strategies
了解靶向蛋白质降解以设计优化的治疗策略
- 批准号:
BB/X007499/1 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Research Grant














{{item.name}}会员




